Focalin XR Novartis Pharmaceuticals Corporation - Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)

Focalin XR is a once-daily extended-release form of Focalin indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults, adolescents and children.

Posted: May 2005

Related Articles:

Focalin XR (dexmethylphenidate) FDA Approval History

View comments

Hide
(web4)